We've leveraged our cutting-edge technologies to build a ground-breaking platform for Immuno-Oncology drug discovery. Our collection of high throughput assays allows you to rapidly identify single agents or combinations that affect T cell and natural killer (NK) cell function.
Gene-Editing in Immune Cells
Gene-editing in immune cells for your Immuno-Oncology project is now even faster than before. Leveraging the latest genome engineering tools, including CRISPR-Cas9, we're able to precisely edit over 10 pre-characterized T-cell, B-cell, and monocytes lines.